Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1933 of 6351
-
Blood test may spot returning lung cancer months before scans
Knowledge-focused OngoingThe goal of this study is to evaluate the clinical utility of a personalized, WES-informed MRD detection approach in patients with early-stage non-small cell lung cancer, with a focus on its association with postoperative recurrence and prognosis, as well as its ability to predic…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a CBD pill help you sleep better? new study investigates
Symptom relief CompletedInsomnia is a disorder in which people have inadequate or poor-quality sleep due to a number of factors, such as difficulty falling asleep, waking up frequently during the night with difficulty returning to sleep, waking up too early in the morning, or having unrefreshing sleep. …
Phase 2 • Sponsor: Defined Research • Aim: Symptom relief
Last updated Jun 26, 2026 15:46 UTC
-
Morning or evening? study tests best time for BP meds in obesity
Disease control Recruiting nowObese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death. Natriuretic Peptides (NPs) are hormones produced by the heart which directly r…
Phase 2/3 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Lower doses, same hope? new trial aims to tame myeloma with fewer side effects
Disease control Recruiting nowThis research study is investigating the safety and effectiveness of using combination of isatuximab, lenalidomide and dexamethasone for the treatment of newly diagnosed multiple myeloma (MM). The study team will use lower doses than is currently standard for these drugs. Lower d…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Zapping the brain to stop seizures: new study hopes to map epilepsy in kids
Knowledge-focused Recruiting nowThe main reason for this research study is to gain information about how the brain makes seizures by causing seizures using very small amounts of current, or electrical stimulation. Using small amounts of current to cause seizures (or stimulate) is not new at CCHMC - it is part o…
Sponsor: Sarah Katie Ihnen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New pill shows promise for Tough-to-Treat bladder cancer
Disease control OngoingThe purpose of this study is to assess the effectiveness of erdafitinib in people with non-muscle invasive bladder cancer (NMIBC) that has come back after standard treatment, such as Bacillus Calmette-Guerin (BCG) or chemotherapy instilled into the bladder. Participants in this s…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Physical therapy may unlock lasting activity for older adults with joint pain
Symptom relief CompletedChronic musculoskeletal conditions (chronic low back pain, knee osteoarthritis, hip osteoarthritis) are the most common causes of long-term disability resulting in a loss of quality-of life for affected individuals and high costs for society. Regular physical activity can reduce …
Sponsor: University of Utah • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New balloon could keep leg arteries open longer
Disease control CompletedThe CVT-SFA Trial investigates the inhibition of restenosis using the CVT Everolimus-coated PTA Catheter in the treatment of de-novo occluded/ stenotic or re-occluded/restenotic superficial femoral or popliteal arteries.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for rare blood cancer: targeted drug shows promise in early trial
Disease control OngoingThis study is being done to examine the safety and effectiveness of loncastuximab tesirine as a possible treatment for participants with Waldenström Macroglobulinemia (WM). The name of the study drug involved in this study is: * Loncastuximab tesirine
Phase 2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Steroid shot before surgery may speed up recovery in seniors
Symptom relief CompletedMajor surgery induces a systemic inflammatory response, which can influence the post-operative morbidity, such as coagulation disorders and post-operative muscle weakness, hampering early recovery after surgery. Single administration of high dose corticosteroids is known to redu…
Phase 4 • Sponsor: Ziekenhuis Oost-Limburg • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Smartwatches could offer an objective measure of ADHD hyperactivity
Knowledge-focused By invitation onlyAttention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Clinical diagnosis of this disorder depends of history taking, parent report, and questionnaire. Attention test such as continuous perfor…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Immune booster shot aims to speed recovery after cord blood transplant
Disease control Recruiting nowThis is an open-labelled and non-controlled Phase I/II clinical trial, evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic ma…
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a common supplement slow MS brain damage? new trial seeks answers.
Disease control OngoingThis study evaluates the effectiveness of N-acetyl cysteine (NAC) in the treatment of progressive multiple sclerosis. Half of the patients will receive NAC, while the other half will receive a placebo.
Phase 2 • Sponsor: Emmanuelle Waubant, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Keytruda takes on deadly thyroid cancer in tiny trial
Disease control OngoingThis is a single-arm, open-label trial designed to evaluate the activity of pembrolizumab therapy in anaplastic thyroid cancer in patients with no curative alternative therapy. Pembrolizumab (Keytruda-Merck) 200 mg, given IV every 3 weeks, until evidence of progression, intoleran…
Phase 2 • Sponsor: Saad A Khan • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New hope for mystery itch: drug targets chronic pruritus
Symptom relief Recruiting nowThe main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO. This is a master protocol which includes 2 parallel-treatment, double-blind, 2- arm Phase 3 staggered studies of similar design (Study A and Study B) in male a…
Phase 3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Donor immune cells take on Hard-to-Treat cancers in early trial
Disease control OngoingA Phase 1, open label, dose escalation and expanded cohort study of P-MUC1C-ALLO1 in adult subjects with advanced or metastatic epithelial derived solid tumors, including but not limited to the tumor types listed below.
Phase 1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New surgery targets hidden cancer in ovarian patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and the effectiveness of hepato-celiac lymphadenectomy in the treatment of primarily diagnosed advanced epithelial ovarian cancer and platinum-sensitive recurrent ovarian cancer.
Sponsor: Shanghai Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Bladder cancer patients who Can't take chemo may get new option
Disease control OngoingThis is a prospective, single-institution, single-arm, phase II clinical trial that tests a novel strategy of neoadjuvant Sasanlimab, an immune checkpoint inhibitor (ICI), in combination with stereotactic body radiation therapy as an in-situ vaccination in patients, who are ineli…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New brain scans aim to diagnose long COVID's hidden damage
Diagnosis OngoingThe overarching goal of this study is to develop PET/MR techniques for the diagnosis of neuropsychiatric post-acute sequelae (PASC) of SARS-CoV-2. The central hypothesis is that immunological and cerebrovascular dysfunction after acute SARS-CoV-2 infections mediate neuropsychiatr…
Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Which hip implant lasts longer? a Head-to-Head trial aims to find out
Disease control OngoingThis study is aimed to provide a clinical and radiographic evaluation of 120 suitable subjects who underwent a total hip arthroplasty with MINIMA stem coupled with Delta TT or Delta ST-C cup.
Sponsor: Limacorporate S.p.a • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC